SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-145706
Filing Date
2022-05-10
Accepted
2022-05-10 07:43:02
Documents
14
Period of Report
2022-05-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d321188d8k.htm   iXBRL 8-K 30052
2 EX-99.1 d321188dex991.htm EX-99.1 9815
6 GRAPHIC g321188g0509234535178.jpg GRAPHIC 3409
  Complete submission text file 0001193125-22-145706.txt   172658

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nexi-20220505.xsd EX-101.SCH 2833
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20220505_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20220505_pre.xml EX-101.PRE 11243
8 EXTRACTED XBRL INSTANCE DOCUMENT d321188d8k_htm.xml XML 3340
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 22907395
SIC: 2834 Pharmaceutical Preparations